# ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

> **NCT00397228** · PHASE2 · COMPLETED · sponsor: **Molecular NeuroImaging** · enrollment: 27 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** ALTROPANE®

## Key facts

- **NCT ID:** NCT00397228
- **Lead sponsor:** Molecular NeuroImaging
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397228, "ALTROPANE® SPECT Imaging in Patients With Parkinson Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00397228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*